Skip to content
  • Who are we
    • At a glance
    • Our mission, promise and values
    • Our story
    • Global presence and locations
    • Executive Leadership
  • Science
    • Science based
    • Research and development
  • Solutions

    Therapeutics

    Aesthetics

    • Breast implants
    • Dermal reconstruction
    • Nevelia
    • Nevelia Pro
    • Surgical procedure
    • Clinical cases
    • Clinical data publications
    • Live webinars
    • Videos
    • Brochures
    • Black and Black Surgical

    Administration systems

    • B2B administration systems
    • administration systems SD products
    • Therapeutics
    • Aesthetics ESTYME®
    • Administration systems
  • Impact
    • CSR commitments and objectives
    • Symatese Foundation
    • Symatese Charters
  • News
  • Careers
  • Contact
  • fr_FR
Linkedin-in
  • fr_FR
  • fr_FR
  • Who are we
    • At a glance
    • Our mission, promise and values
    • Our story
    • Global presence and locations
    • Executive Leadership
  • Science
    • Science based
    • Research and development
  • Solutions
    • Therapeutics
    • Aesthetics ESTYME®
    • Administration systems
  • Impact
    • CSR commitments and objectives
    • Symatese Foundation
    • Symatese Charters
  • News
  • Careers
  • Contact
  • fr_FR
  • Who are we
    • At a glance
    • Our mission, promise and values
    • Our story
    • Global presence and locations
    • Executive Leadership
  • Science
    • Science based
    • Research and development
  • Solutions
    • Therapeutics
    • Aesthetics ESTYME®
    • Administration systems
  • Impact
    • CSR commitments and objectives
    • Symatese Foundation
    • Symatese Charters
  • News
  • Careers
  • Contact
  • fr_FR

Who are we

At a glance
Our mission, promise and values
Our story
Global presence and locations
Executive Leadership

Science

Science based
Research and development

SOLUTIONS

THERAPEUTICS

Therapeutics
Dermal Reconstruction
NEVELIA®
NEVELIA® Pro

AESTHETIC ESTYME®

Aesthethics
ESTYME Dermal fillers
ESTYME Breast implants
Black and black surgical

AESTHETIC SEBBIN

Aesthethics
SEBBIN Breast implants
SEBBIN Body implants
SEBBIN Custom made implants
SEBBIN Lipofliting

Administration systems

Administration systems
B2B Administration systems
Administration system SD products

IMPACT

CSR commitments and objectives
Symatese Foundation
Symatese Charters

NEWS

View our latests news

CAREERS

View open positions

CONTACT

Get in touch

News

SYMATESE Accelerates Global Expansion: Ambitious Growth Strategy

May 16, 2025

SYMATESE announces the commercial Launch of Evolysse™ in the US

April 17, 2025

SYMATESE Secures FDA Approval for EVOLYSSE™

February 14, 2025

SYMATESE previews COLD-X™ TECHNOLOGY at IMCAS

February 7, 2025

SYMATESE DEVICE invites you to Pharmapack 2025

January 3, 2025

SYMATESE reaches a decisive milestone!

October 31, 2024

SYMATESE Announces Submission to U.S. FDA for its Pre-market approval Application for its HA dermal fillers

June 25, 2024

SYMATESE DEVICE at “The Pharma Days” in Geneva

May 6, 2024

Lacrifill®: a new dry eye treatment by Nordic Pharma

April 25, 2024

SYMATESE celebrates 10 years with NEVELIA®

April 11, 2024

SYMATESE launches SYMATESE LAB

April 4, 2024

1st class III product under MDR CE marking

March 19, 2024

Anatomical structures can be reconstructed naturally

Linkedin-in Youtube

Who are we

  • SYMATESE at a glance
  • Our mission, priomise & values
  • Our story
  • Global presence & locations
  • Executive leadership

Science

  • Science based company
  • Research & Development

Solutions

  • Therapeutics
  • Aesthetics
  • Administration systems

Impact

  • Our CSR commitments & objectives
  • SYMATESE Foundation
  • SYMATESE Charters

News

Careers

Contact

Copyright © Symatese 2024

  • Privacy policy
  • Legal notice